FDA Adverse Event Malfunction Summary report: N

UNICEL® DXI 800 ACCESS IMMUNOASSAY SYSTEM

MDR report key: 1980920 · Received February 7, 2011

Report

Report Number
2122870-2011-00339
Event Type
Malfunction
Date Received
February 7, 2011
Date of Event
October 5, 2010
Report Date
October 7, 2010
Manufacturer
BECKMAN COULTER INC.
Product Code
JJE
PMA / PMN Number
K023764
Removal / Correction Number
N/A
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AL, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

BOTH LEVELS OF CEA2 QC WERE WITHIN THE CUSTOMER'S ESTABLISHED RANGES PRIOR TO AND AFTER THE EVENT. SERVICE WAS NOT DISPATCHED FOR THIS EVENT AS THE CUSTOMER IS NOT QUESTIONING INSTRUMENT PERFORMANCE AT THIS TIME. THE CUSTOMER SENT THE SAMPLE TO CUSTOMER PRODUCT LINE SUPPORT FOR ADDITIONAL TESTING. CPLS WAS UNABLE TO IDENTIFY A PATIENT SOURCE INTERFERENT. A DEFINITIVE ROOT CAUSE HAS NOT BEEN DETERMINED TO DATE FOR THIS EVENT. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A RETROSPECTIVE REVIEW OF COMPLAINTS WITHIN THE DATE RANGE (B)(6) 2010 FOR ADDITIONAL REPORTABLE EVENTS/OCCURRENCES. THIS REPORTABLE EVENT CAPTURES THE SAMPLES FOR ONE PATIENT THAT IS RELATED TO THE PREVIOUSLY SUBMITTED MDR 2122870-2010-00695.

Description of Event or Problem · 1

A CUSTOMER CONTACTED BECKMAN COULTER INC (BCI) REGARDING REPRODUCIBLE, ELEVATED CARCINOEMBRYONIC ANTIGEN (CEA) RESULTS, ABOVE THE NORMAL REFERENCE INTERVAL, GENERATED BY THE UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM FOR ONE PATIENT. SUBSEQUENT TESTING ON AN ALTERNATE METHODOLOGY PRODUCED DISCORDANT LOWER RESULTS WITHIN THE NORMAL REFERENCE INTERVAL. THE ERRONEOUS RESULTS WERE REPORTED OUT OF THE LABORATORY. THE CUSTOMER DID NOT RECEIVE ANY REPORT OF PATIENT INJURY REQUIRING MEDICAL INTERVENTION OR CHANGE TO PATIENT TREATMENT ATTRIBUTED OR CONNECTED WITH THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 UNICEL® DXI 800 ACCESS IMMUNOASSAY SYSTEM DISCRETE PHOTOMETRIC CHEMISTRY ANALYZER JJE BECKMAN COULTER INC. DXI 800 N/A

Patients

Seq Age Sex Outcome Treatment
1